Reference and target region modeling of [11C]-(R)-PK11195 brain studies

Journal of Nuclear Medicine

Volumn 48, Issue 1, 2007, Pages 158-167

  Turkheimer, Federico E ^a,b,d   Edison, Paul ^a,b   Pavese, Nicola ^b   Roncaroli, Federico ^a   Anderson, Alexander N ^a   Hammers, Alexander ^a,b   Gerhard, Alexander ^b,c   Hinz, Rainer ^b   Tai, Yan F ^a,b   Brooks, David J ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d Department of Clinical Neuroscience ^*  (United Kingdom)

Author keywords

Microglia; PET; PK11195; Supervised clustering

Indexed keywords

N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE CARBOXAMIDE 11; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CARBON; ISOQUINOLINE DERIVATIVE;

ADULT; ALGORITHM; ALZHEIMER DISEASE; ARTICLE; CASE REPORT; CONTROLLED STUDY; DEVICE; FEMALE; GRAY MATTER; HUMAN; HUNTINGTON CHOREA; IMAGE ANALYSIS; IMAGING SYSTEM; KINETICS; MALE; MICROGLIA; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANK SHAPING EXPONENTIAL SPECTRAL ANALYSIS; RELIABILITY; REPRODUCIBILITY; SIGNAL TRANSDUCTION; SIMPLIFIED REFERENCE TISSUE MODEL; SPECTROSCOPY; TEST RETEST RELIABILITY; AUTOMATED PATTERN RECOGNITION; BRAIN; CASE CONTROL STUDY; CLUSTER ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; METHODOLOGY; PATHOLOGY; STATISTICAL MODEL; TIME;

ALGORITHMS; ANTINEOPLASTIC AGENTS; BRAIN; CARBON RADIOISOTOPES; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; HUMANS; HUNTINGTON DISEASE; IMAGE INTERPRETATION, COMPUTER-ASSISTED; ISOQUINOLINES; KINETICS; MODELS, STATISTICAL; PATTERN RECOGNITION, AUTOMATED; POSITRON-EMISSION TOMOGRAPHY; TIME FACTORS;

EID: 33847333156     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hertz L. Binding characteristics of the receptor and coupling to transport proteins. In: Giessen-Crouse E, ed. Peripheral Benzodiazepine Receptors. London, U.K.: Academic Press; 1993:27-51.
2. Gavish M, Bachman I, Shokrun R, et al. Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev. 1999;51:629-650.
3. Banati RB. Visualising microglial activation in vivo. Glia. 2002;40:206-217.
4. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996;19:312-318.
5. Flugel A, Bradl M, Kreutzberg GW, Graeber MB. Transformation of donor-derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy. J Neurosci Res. 2001;66:74-82.
6. Banati RB, Cagnin A, Brooks DJ, et al. Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury. Neuroreport. 2001;12:3439-3442.
7. 11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. Nucl Med Biol. 1994;21:573-581.
8. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996;4:153-158.
9. 11C]PK11195 brain studies. J Cereb Blood Flow Metab. 2005;25:842-851.
10. 11C](R)-PK11195 studies. J Cereb Blood Flow Metab. 2006;26:1431-1441.
11. Mrak RE, Griffin WS. Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging. 2005;26:349-354.
12. 11C](R)-PK11195 PET in corticobasal degeneration. Mov Disord. 2004;19:1221-1226.
13. Gunn RN, Lammertsma AA, Cunningham VJ. Parametric imaging of ligand-receptor interactions using a reference tissue model and cluster analysis. In: Carson R, Daube-Witherspoon M, Herscovitch P, eds. Quantitative Functional Brain Imaging with Positron Emission Tomography. San Diego CA: Academic Press; 1998:401-406.
14. Chen J, Gunn S, Nixon M, Myers R, Gunn R. A supervised method for PET reference region extraction. Proceedings of Medical Image Understanding and Analysis. London, U.K.; July 2000:179-182.
15. Spinks TJ, Jones T, Bloomfield PM, et al. Physical characteristics of the ECAT EXACT3D positron tomograph. Phys Med Biol. 2000;45:2601-2618.
16. Pavese N, Gerhard A, Tai YF, et al. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology. 2006;66:1638-1643.
17. Ranicar AS, Williams CW, Schnorr L, et al. The on-line monitoring of continuously withdrawn arterial blood during PET studies using a single BGO/photomultiplier assembly and non-stick tubing. Med Prog Technol. 1991;17:259-264.
18. 11C]Scherring 23390. J Labelled Comp Radiopharm. 1993;518-520.
19. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage. 1997;6:279-287.
20. Lawson C, Hanson R. Solving Least Squares Problems. Englewood Cliffs, NJ: Prentice-Hall; 1974:160-165.
21. Sapp E, Kegel KB, Aronin N, et al. Early and progressive accumulation of reactive microglia in the Huntington disease brain. J Neuropathol Exp Neurol. 2001;60:161-172.
22. Cunningham VJ, Jones T. Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab. 1993;13:15-23.
23. Turkheimer FE, Hinz R, Gunn RN, Aston JA, Gunn SR, Cunningham VJ. Rank-shaping regularization of exponential spectral analysis for application to functional parametric mapping. Phys Med Biol. 2003;48:3819-3841.
24. Gunn RN, Gunn SR, Cunningham VJ. Positron emission tomography compartmental models. J Cereb Blood Flow Metab. 2001;21:635-652.
25. Hammers A, Allom R, Koepp MJ, et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp. 2003;19:224-247.
26. Charbonneau P, Syrota A, Crouzel C, Valois JM, Prenant C, Crouzel M. Peripheral-type benzodiazepine receptors in the living heart characterized by positron emission tomography. Circulation. 1986;73:476-483.
27. Cagnin A, Brooks DJ, Kennedy AM, et al. In-vivo measurement of activated microglia in dementia. Lancet. 2001;358:461-467.